Kent Imaging Inc., a leading innovator in multispectral oxygenation imaging, designs, manufactures, and markets imaging technology to improve plastic surgery, colorectal surgery, trauma, wound care, limb salvage, podiatry, burns and cardiac specialties. The team at Kent Imaging is committed to improving patient outcomes by delivering innovative and practical solutions for the healthcare industry. Kent Imaging holds multiple patents in medical technology and is currently commercializing the breakthrough multispectral imaging solutions that assesses tissue oxygen saturation. The company is headquartered in Calgary, Alberta, Canada, and has locations in Chicago, Los Angeles, Salt Lake City and Seattle.
Don Chapman, Executive Chairman
A serial entrepreneur with over 40 years of experience, Mr. Chapman is the founder of Kent Imaging. He has strategically grown the company from inception to market leadership and continues to provide oversight and leadership. His extensive background in technology and product development brings exceptional value to the team.
Pierre Lemire, Chief Executive Officer
A technology commercialization expert with over 30 years of experience in the high tech world of imaging, Mr. Lemire provides the day to day leadership for Kent Imaging. His past roles as a CTO at Autodesk Inc and Co-Founder of Calgary Scientific provide key experiences that he uses to guide Kent Imaging’s corporate strategy and vision.
Dr. Adam Landsman, Chief Medical Officer
Dr. Adam Landsman is the Chief Medical Officer for Kent Imaging and in this role guides the medical use of Kent’s technology. He is the Chief of Podiatry at the Cambridge Health Alliance in Boston and provides expert care for all foot and ankle conditions. He is a board-certified foot surgeon and serves as an Assistant Professor of Surgery at Harvard Medical School.
Dr. Michael Sowa, Chief Science Officer
Dr. Sowa is Chief Science Officer for Kent Imaging and is responsible for scientific research and product innovation. He spent 24 years leading the National Research Council of Canada’s spectroscopy development team where his team invented and patented the NIR technology licensed by Kent Imaging as well as ICG imaging systems. He has over 100 publications and continues to extend Kent’s patent portfolio.
Will Siewert, Vice President of Sales, NA
Will Siewert is a multi-award winning strategic sales executive with nearly 2 decades of medical device experience including commercial launches for perfusion assessment technologies of Spy, Luna, and Pinpoint. He has experience as trainer and sales leader within multiple organizations including Lifecell, Karl Storz and Covidien. Mr. Siewert directs Kent’s US product sales in the plastic/reconstructive surgical and limb salvage markets.
Sandra Jenks, Vice President of Marketing
With over 25 years of domestic and global marketing experience in paramedical, pharmaceutical and high tech industries including Merck Canada and SMART Technologies ULC, Ms. Jenks leads the marketing arm of Kent Imaging. With a results focus, Ms. Jenks is responsible for marketing and communication strategies, campaigns, product introductions and brand management for the organization.
Liz Newell, Director of Clinical Research and Training
Ms Newell is Kent’s Clinical Manager and is responsible for client training and the clinical validation of Kent's products. She holds a Masters degree from the University of Calgary’s Biomedical Technology program.